The turnover for Biotechnology Research and Experimental Development in Austria is projected to grow steadily from 2024 to 2028, starting at €306.3 million in 2024 and reaching €309 million by 2028.
Year-on-year variation shows a consistent increase of approximately 0.2% - 0.3% each year.
The turnover stood at €305.5 million in 2023, thus demonstrating a slight but steady upward trend from 2023 to 2024.
The Compound Annual Growth Rate (CAGR) for the period from 2024 to 2028 is modest, indicating average annual growth close to 0.2%.
Looking ahead, key trends to monitor include advancements in biotechnological innovations, government funding policies, and potential impacts from global biotech market dynamics. These factors will play crucial roles in shaping the future trajectory of Austria's biotechnology research and experimental development sector.
